Reduced dopamine function within the medial shell of the nucleus accumbens enhances latent inhibition

Pharmacology Biochemistry and Behavior

Volumn 98, Issue 1, 2011, Pages 1-7

  Nelson, A J D ^a   Thur, K E ^a   Horsley, R R ^a   Spicer, C ^a   Marsden, C A ^a   Cassaday, H J ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Core; Dopamine; Latent inhibition; Nucleus accumbens; Shell

Indexed keywords

DESIPRAMINE; DOPAMINE; HALOPERIDOL; NORADRENALIN; OXIDOPAMINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; EMOTION; LATENT INHIBITION; MALE; MONOAMINE METABOLISM; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT;

ANIMALS; ASSOCIATION LEARNING; CONDITIONING (PSYCHOLOGY); DOPAMINE; DOPAMINE ANTAGONISTS; EXTINCTION, PSYCHOLOGICAL; HALOPERIDOL; INHIBITION (PSYCHOLOGY); MALE; NOREPINEPHRINE; NUCLEUS ACCUMBENS; OXIDOPAMINE; RATS; RATS, WISTAR;

ANIMALIA;

EID: 78650591031     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2010.11.025     Document Type: Article

References (53)

1. R.P. Abelson Statistics as principled argument 1995 Lawrence Erlbaum Associates Hove, UK 104 131
2. I. Baruch, D.R. Hemsley, and J.A. Gray Differential performance of acute and chronic schizophrenics in a latent inhibition task J Nerv Ment Dis 176 1988 598 606
3. H.W. Berendse, Y. Galis de Graaf, and H.J. Groenewegen Topographical organization and relationship with ventral striatal compartments of prefrontal corticostriatal projections in the rat J Comp Neurol 316 1992 314 347
4. S.M. Boye, R.J. Grant, and P.B. Clarke Disruption of dopaminergic neurotransmission in nucleus accumbens core inhibits the locomotor stimulant effects of nicotine and d-amphetamine in rats Neuropharmacology 40 2001 792 805
5. M. Correa, B.B. Carlson, A. Wisniecki, and J.D. Salamone Nucleus accumbens dopamine and work requirements on interval schedules Behav Brain Res 137 2002 179 187
6. M.S. Cousins, J.D. Sokolowski, and J.D. Salamone Different effects of nucleus accumbens and ventrolateral striatal dopamine depletions on instrumental response selection in the rat Pharmacol Biochem Behav 46 1993 943 951
7. A.Y. Deutch, M.C. Lee, and M.J. Iadarola Regionally specific effects of atypical antipsychotic drugs on striatal Fos expression: the nucleus accumbens shell as a locus of antipsychotic action Mol Cell Neurosci 3 1992 332 341
8. G. Di Chiara Nucleus accumbens shell and core dopamine: differential role in behaviour and addiction Behav Brain Res 137 2002 75 114 (Pubitemid 35346430)
9. R.P. Dilts Jr., T.E. Helton, and J.F. McGinty Selective induction of Fos and FRA immunoreactivity within the mesolimbic and mesostriatal dopamine terminal fields Synapse 13 1993 251 263
10. B.A. Ellenbroek, D.A. Knobbout, and A.R. Cools The role of mesolimbic and nigrostriatal dopamine in latent inhibition as measured with the conditioned taste aversion paradigm Psychopharmacology 129 1997 112 120
11. J. Feldon, A. Shofel, and I. Weiner Latent inhibition is unaffected by direct dopamine agonists Pharmacol Biochem Behav 38 1991 309 314
12. S.B. Floresco, S. Ghods-Sharifi, C. Vexelman, and O. Magyar Dissociable roles for the nucleus accumbens core and shell in regulating set shifting J Neurosci 26 2006 2449 2457
13. G. Gal, D. Schiller, and I. Weiner Latent inhibition is disrupted by nucleus accumbens shell lesion but is abnormally persistent following entire nucleus accumbens lesion: the neural site controlling the expression and disruption of the stimulus preexposure effect Behav Brain Res 162 2005 246 255
14. J.A. Gray, J. Feldon, J.N.P. Rawlins, D.R. Hemsley, and A.D. Smith The neuropsychology of schizophrenia Behav Brain Sci 14 1991 1 20
15. N.S. Gray, A.D. Pickering, D.R. Hemsley, S. Dawling, and J.A. Gray Abolition of latent inhibition by a single 5 mg dose of d-amphetamine in man Psychopharmacology 107 1992 425 430
16. H.J. Groenewegen, C.I. Wright, A.V. Beijer, and P. Voorn Convergence and segregation of ventral striatal inputs and outputs Ann NY Acad Sci 877 1999 49 63
17. S.N. Haber, J.L. Fudge, and N.R. McFarland Striatonigrostriatal pathways in primates form an ascending spiral from the shell to the dorsolateral striatum J Neurosci 20 2000 2369 2382
18. J. Jeanblanc, A. Hoeltzel, and A. Louilot Differential involvement of dopaminergic neurons innervating the core and shell subregions of the nucleus accumbens in latent inhibition and affective perception Neuroscience 111 2002 315 323
19. J. Jeanblanc, A. Hoeltzel, and A. Louilot Differential involvement of dopamine in the anterior and posterior parts of the dorsal striatum in latent inhibition Neuroscience 118 2003 233 241
20. M.H. Joseph, S.L. Peters, P.M. Moran, G.A. Grigoryan, A.M.J. Young, and J.A. Gray Modulation of latent inhibition in the rat by altered dopamine transmission in the nucleus accumbens at the time of conditioning Neuroscience 101 2000 921 930
21. S. Killcross, and T.W. Robbins Differential effects of intra-accumbens and systemic amphetamine on latent inhibition using an on-baseline, within-subject conditioned suppression paradigm Psychopharmacology 110 1993 479 489
22. V. Kumari, P.A. Cotter, O.F. Mulligan, S.A. Checkley, N.S. Gray, and D.R. Hemsley Effects of d-amphetamine and haloperidol on latent inhibition in healthy male volunteers J Psychopharmacol 13 1999 398 405
23. L. Lacroix, L.M. Broersen, J. Feldon, and I. Weiner Effects of local infusions of dopaminergic drugs into the medial prefrontal cortex of rats on latent inhibition, prepulse inhibition and amphetamine induced activity Behav Brain Res 107 2000 111 121
24. R.E. Lubow, and A.U. Moore Latent inhibition: the effect of non-reinforced preexposure to the conditional stimulus J Comp Physiol Psychol 52 1959 415 419
25. G.E. Meredith, P. Ypma, and D.S. Zahm Effects of dopamine depletion on the morphology of medium spiny neurons in the shell and core of the rat nucleus accumbens J Neurosci 15 1995 3808 3820
26. G.E. Meredith, B.A. Baldo, M.E. Andrezjewski, and A.E. Kelley The structural basis for mapping behavior onto the striatum and its subdivisions Brain Struct Funct 213 2008 17 27
27. C.A. Murphy, M. Pezze, H. Russig, and J. Feldon Differential involvement of dopamine in the shell of the nucleus accumbens in the expression of latent inhibition to an aversively conditioned stimulus Neuroscience 97 2001 469 477
28. A.J.D. Nelson, K.E. Thur, C.A. Marsden, and H.J. Cassaday Catecholaminergic depletion within the prelimbic medial prefrontal cortex enhances latent inhibition Neuroscience 170 2010 99 106
29. A.J.D. Nelson, K.E. Thur, C.A. Marsden, and H.J. Cassaday Dissociable roles of dopamine within the core and medial shell of the nucleus accumbens in memory for objects and place Behav Neurosci 124 2010 789 799
30. Nelson, A.J.D., Thur, K.E., Marsden, C.A., Cassaday, H.J., Dopamine in nucleus accumbens: salience modulation in latent inhibition and overshadowing. J Psychopharmacol; in press. DOI: 10.1177/0269881110389211.
31. J.A. Parkinson, T.W. Robbins, and B.J. Everitt Selective excitotoxic lesions of the nucleus accumbens core and shell differentially affect aversive Pavlovian conditioning to discrete and contextual cues Psychobiology 27 1999 256 266
32. G. Paxinos, and C. Watson The rat brain in stereotaxic coordinates 5th ed. 2005 Academic Press San Diego
33. H.H. Pothuizen, A.L. Jongen-Rêlo, J. Feldon, and B.K. Yee Double dissociation of the effects of selective nucleus accumbens core and shell lesions on impulsive-choice behaviour and salience learning in rats Eur J Neurosci 22 2005 2605 2616
34. C. Ruob, I. Weiner, and J. Feldon Haloperidol-induced potentiation of latent inhibition: interaction with parameters of conditioning Behav Pharmacol 9 1998 245 253
35. J.D. Salamone, A. Wisniecki, B.B. Carlson, and M. Correa Nucleus accumbens dopamine depletions make animals highly sensitive to high fixed ratio requirements but do not impair primary food reinforcement Neuroscience 105 2001 863 870
36. D. Schiller, and I. Weiner Basolateral amygdala lesions in the rat produce an abnormally persistent latent inhibition with weak preexposure but not with context shift Behav Brain Res 163 2005 115 121
37. D. Schiller, L. Zuckerman, and I. Weiner Abnormally persistent latent inhibition induced by lesions to the nucleus accumbens core, basolateral amygdala and orbitofrontal cortex is reversed by clozapine but not by haloperidol J Psychiatr Res 40 2006 167 177
38. L.H.L. Sellings, and P.B.S. Clarke Segregation of amphetamine reward and locomotor stimulation between nucleus accumbens medial shell and core J Neurosci 23 2003 6295 6303
39. L.H.L. Sellings, G. Baharnouri, L.E. McQuade, and P.B.S. Clarke Rewarding and aversive effects of nicotine are segregated within the nucleus accumbens Eur J Neurosci 28 2008 342 352
40. E. Shadach, I. Gaisler, D. Schiller, and I. Weiner The latent inhibition model dissociates between clozapine, haloperidol and ritanserin Neuropsychopharmacology 23 2000 151 161
41. J.D. Sokolowski, and J.D. Salamone The role of accumbens dopamine in lever pressing and response allocation: effects of 6-OHDA injected into core and dorsomedial shell Pharmacol Biochem Behav 59 1998 557 566
42. P.R. Solomon, and D.M. Staton Differential effects of microinjections of d-amphetamine into the nucleus accumbens or the caudate putamen on the rat's ability to ignore an irrelevant stimulus Biol Psychiatry 17 1982 743 756
43. P.R. Solomon, A. Crider, J.W. Winkelman, A. Turi, R.M. Kamer, and L.J. Kaplan Disrupted latent inhibition in the rat with chronic amphetamine or haloperidol-induced supersensitivity: relationship to schizophrenic attention disorder Biol Psychiatry 16 1981 519 537
44. C.-T. Tai, H.J. Cassaday, J. Feldon, and J.N.P. Rawlins Both electrolytic and excitotoxic lesions of nucleus accumbens disrupt latent inhibition of learning in rats Neurobiol Learn Mem 64 1995 36 48
45. Y.C. van Dongen, J.-M. Deniau, C.M.A. Pennartz, Y. Galis-de Graaf, P. Voorn, and A.-M. Thierry Anatomical evidence for direct connections between the shell and core subregions of the rat nucleus accumbens Neuroscience 136 2005 1049 1071
46. I. Weiner Neural substrates of latent inhibition: the switching model Psychol Bull 108 1990 442 461
47. I. Weiner The "two-headed" latent inhibition model of schizophrenia: modelling positive and negative symptoms and their treatment Psychopharmacology 169 2003 257 297
48. I. Weiner, and M. Arad Using the pharmacology of latent inhibition to model domains of pathology in schizophrenia and their treatment Behav Brain Res 204 2009 369 386
49. I. Weiner, and J. Feldon Facilitation of latent inhibition by haloperidol in rats Psychopharmacology 91 1987 248 253
50. I. Weiner, R.E. Lubow, and J. Feldon Abolition of the expression but not the acquisition of latent inhibition by chronic amphetamine in rats Psychopharmacology 83 1984 194 199
51. I. Weiner, G. Gal, J.N.P. Rawlins, and J. Feldon Differential involvement of the shell and core subterritories of the nucleus in latent inhibition and amphetamine-induced activity Behav Brain Res 81 1996 123 133
52. H. Williams, H.E. Wellman, D. Geaney, J. Feldon, P. Cowen, and J.N.P. Rawlins Haloperidol enhances latent inhibition in visual tasks in healthy people Psychopharmacology 133 1997 262 268
53. D.S. Zahm, and J.S. Brog On the significance of subterritories in the 'accumbens' part of the rat ventral striatum Neuroscience 50 1992 751 767